Poster discussion 1 — ASN Events

Poster discussion 1 — ASN Events

Poster discussion 1

Chairs: Anna Boltong & Thomas Jagoe

Presenters to stand next to posters

The use of label-free LC-MS/MS approach to identify signaling pathways associated with prostate cancer radioresistance (#211)

Anticancer drug transport to breast cancer cells using mineral nanoparticles (#212)

Chia Yuen Chong

Selective cytotoxicity of gemcitabine on superficial malignant vs. normal human urothelial cells and the effects of hyperthermia (#214)

Gemcitabine enhances release of ATP but not acetylcholine or PGE₂ from bladder urothelial cells (#215)

Relative cytotoxic potency and cell death mechanisms of α1-adrenoceptor antagonists on prostate cancer cell lines (#216)

Pre-treatment information needs and preferences of radiotherapy patients (#217)

Alterations in bladder urothelial acetylcholine, ATP, prostaglandin E2 and inflammatory cytokines by the chemotherapeutic agent epirubicin (#218)

Intravesical mitomycin C treatment alters urothelial function and detrusor contraction (#219)

Energy and protein intake in oncology patients at risk of skeletal muscle atrophy (#220)

Effects of combining Taxol and SC-560 on angiogenesis of ovarian cancer in vivo (#221)

The effect of caffeine on ABCB1 efflux transporter function (#222)

Modulation of P-glycoprotein function by curcumin-loaded nanoparticles (#223)

The new selective GLP-2 receptor agonist, Elsiglutide, improves irinotecan-induced diarrhoea and mucositis in the rat. (#224)

Apoptosis, proliferation and inflammation are improved after treatment with the new selective GLP-2 receptor agonist, Elsiglutide, in a rat model of irinotecan-induced mucositis. (#225)

Cyclophosphamide and ifosfamide enhancement of bladder sensory nerve activity (#226)

Diagnosis and molecular targeting for individualized treatment of patients with pre-neoplastic lesions and locally advanced cervical cancer (#227)

Pablo Moreno Acosta

No More Vague Descriptors: Building competency in assessment, in collaboration with all stakeholders. The development of a comprehensive assessment tool for patients in the Day Oncology setting at Cabrini Malvern (#228)

Briege O'Donnell

Somatic mutations of the EGFR, KRAS and BRAF genes: homogeneity in single cells from cell lines and heterogeneity in circulating epithalial tumor cells (CETC) as determined using the Cobas® z 480 analyzer (#229)

Katharina Pachmann

A complex Qstream© pain assessment intervention on cancer nurses’ pain screening and assessment practices: results from a quasi-experimental study. (#230)

Jane L Phillips

Upregulation of RORα inhibit proliferation, invasion and migration of human gastric cancer cells induced by diallyl disulfide (#231)

Why early treatment of obesity matters: pAkt/mTor and glycolysis is activated in obese women during the initiation of triple-negative breast cancers and can be targeted by metformin chemoprevention (#232)

Victoria Seewaldt

β-carotene, a carotenoid, is a potential inhibitor of multidrug resistant protein (#234)

Integrated Target Discovery in the EMPathy Breast Cancer Network - Multidimensional Analysis of Epithelial Mesenchymal Plasticity (EMP) in Experimental Systems. (#236)

Erik (Rik) W Thompson

Preventive screening for cancer among people attending an Aboriginal Community Controlled Health Service (#237)

Effects of high dose thoracic radiotherapy with concomitant and sequential trastuzumab on isolated rat aorta: A functional study (#239)

c-myc Plays Part in Drug Resistance Mediated by Bone Marrow Stromal Cells in Acute Myeloid Leukemia (#240)

Combined Inhibition Of BTK And PI3Kδ As A Potential Therapeutic Strategy In Mantle Cell Lymphoma (#241)

Improving patient experience in a day oncology service (#242)

The significance of data in capturing a bird’s eye view of a Hospital and Health Service's (HHS) progress (#245)

Using an action research approach to quality improvement of chemotherapy day unit documentation: Engaging health professionals and implementing sustainable change (#246)

Filling the gaps: Implementation and evaluation of the Haematology/Oncology Plan of Care Documentation in a Chemotherapy Day Unit (#247)

Chemotherapy services, safety hierarchy – What you need to know (#248)

Outreach care in a changing health landscape – Making the link (#249)

The ‘specter’ of cancer: Secondary trauma for health professionals providing cancer support and counseling (#250)

Lauren J. Breen

Reducing health costs by treating low-risk neutropenic fever patients at home (#251)

Christine Brown

Achieving consensus in the management of neutropenic fever and sepsis in cancer (#252)

Christine Brown

Involving family in treatment decision-making: A new conceptual framework and consultation strategies (#253)

Cancer Council Helpline 13 11 20: Who uses this information and support service – and why not? (#254)

Malnutrition prevalence in an outpatient cancer care setting (#255)

Belinda Camilleri

The evaluation of clinical pharmacy services in an ambulatory cancer day care unit (#256)

Christine V. Carrington

Time from diagnosis of rectal adenocarcinoma to commencement of long course chemoradiotherapy (LCCRT) for metropolitan versus rural patients referred to a Queensland tertiary referral hospital (#257)

Hayden Christie

A 15 year longitudinal study of breast cancer treatment outcomes in a region (#258)

Radiotherapy for people with cancer: What do written information materials tell them? (#259)

Haryana M. Dhillon

Implementation of a comprehensive geriatric assessment program at the Royal Perth Hospital (RPH) for newly diagnosed older cancer patients (#260)

Fast track colonoscopy for positive faecal occult blood testing (+FOBT) in a public hospital setting (#261)

You can lead a horse to water, but you can’t make it drink: Does a needs assessment tool increase discussion of psychosocial concerns of people with advanced cancer? (#262)

Documentation of antimicrobial therapy in haematology and oncology - A nursing led Antimicrobial Stewardship intervention pilot project (#263)

Lung cancer MDT activity in Queensland: are we making any progress? (#264)

Partnering with patients: a symptom management diary and passport – Created by our patients and clinical partners with clear purpose (#265)

Unplanned allied health admissions to hospital for people newly diagnosed with cancer (#266)

Queensland Cancer Quality Index: tracking Queensland’s progress in improving cancer care (#267)

Results of an electronic oncology pharmacy observational quality assurance audit tool (#268)

Successful management of etoposide hypersensitivity in patients with gynaecological malignancies (#269)

How much do cancer care clinicians know about cancer malnutrition? (#270)

Patients with lower health literacy in radiation oncology: A nursing perspective (#271)

Examining determinants of “access” to radiotherapy – Does the introduction of a local publicly funded radiotherapy service to regional NSW impact on the uptake of breast conserving treatment for early breast cancer here? (#272)

Patient-reported experience of care by prostate cancer specialist nursing service (#273)

Why are a large proportion of prostate cancer cases recorded as having “unknown” stage of disease in an Australian population-based registry? A study of possible health service factors (#274)

Melanoma in a rural Australia, a retrospective 10 year audit of diagnosis and management in the Wimmera. (#276)

James A McCracken

Cetuximab use in metastatic colorectal cancer at five large Queensland public hospitals: comparison to key clinical trials (#277)

Daniel McKavanagh

Examining the general practitioner perspective on utilising family history to screen for colorectal cancer. (#278)

Sundresan Naicker

Music’s relevance for people affected by cancer across the span: Implications for cancer care (#279)

Clare O'Callaghan

Allied health integrated regional pathway for head and neck cancer patients (#280)

Juanine Passfield

Optimal Care Pathways: Achievements and future directions (#281)

Alexandra Philpott

Research Governance for regional clinical trials. (#282)

Sandra Robinson

The establishment of chemo@home: An integrated model of patient-centred service delivery for chemotherapy patients (#283)

Evaluating an evidence-based care pathway for the management of anxiety and depression in cancer care: A Delphi Consensus Study. (#284)

Defining and prioritising success factors for coordinated cancer care (#285)

Barriers to radiotherapy utilization: Consumer perceptions of issues that may influence radiotherapy related decisions (#286)

Puma Sundaresan

Health Professionals perceptions of the impact of access and treatment related practicalities on referrals for radiotherapy and its uptake by consumers (#287)

Puma Sundaresan

Health service access for Aboriginal people associated with level of Aboriginal community engagement (#288)

Dianne O'Connell

Oncology patients overwhelmingly support tissue banking (#289)

How good is the quality of evidence for grief counselling? A systematic review (#290)

Empowering youth engagement through the Victorian and Tasmanian Youth Cancer Advisory Board (YCAB) (#291)

Samantha A Van Staalduinen

A process-based IT system to manage multidisciplinary meetings in a more flexible way (#292)

Stephen Vaughan

Rural oncology care via teleoncology and outreach clinics: patient and staff perspectives and comparisons. (#293)

Nivolumab and ipilimumab in first-line non-small-cell lung carcinoma (NSCLC): interim phase I results (#294)

Scott J Antonia

DHMEQ may provide a therpeutic option in targeting inflammatory mediated acquired and intrinsic cisplatin resistance in non-small cell lung cancer (#295)

Anne-Marie Baird

Sustained exposure to TNF-α and IL-1β increases the invasion, adhesion and proliferative potential of a normal bronchial epithelial cell line (#296)

Anne-Marie Baird

Epidermal Growth Factor Receptor (EGFR) co-mutated advanced non-small cell lung cancer (NSCLC) and response to EGFR tyrosine kinase inhibitors (TKIs) (#297)

Megan B. Barnet

The frequency of allied health interventions to lung cancer patients at Sunshine Hospital Radiotherapy Centre: Data to guide future service delivery (#298)

Nivolumab in patients with advanced non-small-cell lung cancer (NSCLC): survival and clinical activity by subgroup analysis. (#299)

Julie R Brahmer

Predictors of postoperative mortality after lung cancer surgery (#301)

Patterns of MDT review vary by HHS of residence for NSCLC patients in Queensland (#302)

Systemic treatments in advanced non-small cell lung cancer (NSCLC): a systematic review (#303)

James P Harrison

Prognosis of dynamic MR imaging and diffusion weighted imaging for stage III non-small cell lung cancer patients treated with concurrent chemo-radiotherapy (#304)

Circulating tumor cells in peripheral and pulmonary venous blood predict poor long-term survival in surgically resected non-small cell lung cancer patients (#305)

The feasibility of a pragmatic distance-based intervention to increase physical activity in lung cancer survivors (#306)

Carolyn McIntyre

Survival times of patients with metastatic non-small cell lung cancer (NSCLC) starting first-line chemotherapy in routine clinical practice versus contemporary randomised trials (#307)

EBUS replaces other invasive diagnostic investigations and does not impact on time to management decision for lung cancer (#309)

Neli Slavova-Azmanova

Under hypoxic tumor microenvironment, DT-13 inhibited human lung adenocarcinoma growth and metastasis via changing the distribution and down-regulation expression of NMⅡA (#310)

Head and neck cancer (HNC) patients beyond 2 years of disease control: Preliminary analysis of ILEA (Intensity modulated radiotherapy late effect assessment) scale. (#311)

Shifts in perceptions of self associated with the experience of ovarian cancer (#312)

Rebecca Carlson

Family functioning during oncology treatment: International perspectives (#313)

Elisabeth Coyne

Development of an evidence based symptom checklist for detecting symptoms of recurrence in women with endometrial cancer (#314)

Prevalence and associates of the top high/very high unmet needs of Australian haematological cancer survivors (#315)

A comparison of the unmet needs of younger and older adult haematological cancer survivors (#316)

Emotion-regulating coping processes in men with cancer (#317)

Development and evaluation of an online education model on cancer survivorship & supportive nursing care (#318)

Michael Jefford

Living with multiple myeloma: a focus group study of concerns and unmet needs (#319)

Leanne Monterosso

Understanding lymphoma and leukemia survivors’ concerns: a focus group study (#320)

Leanne Monterosso

Qualitative results of the exercise programming preferences and activity levels among adolescents and young adults who have had an experience of cancer. (#321)

Clinical assessment of cancer-related fatigue: current practice vs. clinical guidelines (#322)

Elizabeth JM Pearson

Bone health management of breast and prostate cancer survivors receiving hormonal therapy (#323)

Which strategies have been demonstrated to be effective in managing bone loss in breast and prostate cancer survivors post hormone therapy, and how well are they employed in clinical practice? (#324)

Nutritional status as a determinant of survival in women with gynecological tumors (#325)

Camila S. Rodrigues

Integrative Literature Review of Instruments used to assess Informational and Practical Needs of Acute Leukaemia and Lymphoma Survivors. (#326)

Using web-enabled technology to support men with prostate cancer (#327)

Towards a paradigm shift: psycho-social stress in cancer patients living in rural regions, following active therapy, with care not augmented by a formal Survivorship Care Program (#328)

Mari P Lashbrook

The Psychological Impact of a Pilot Whole-Body Screening Trial (SMOC) on individuals with Li –Fraumeni Syndrome (#329)

PARAGON- Phase II study of aromatase inhibitors in women with potentially hormone responsive recurrent/metastatic gynaecological neoplasms: ANZGOG 0903 (#330)

Linda Mileshkin

The Inherited Cancer Connect (ICCon) mutation-carrier database (#331)

Comparing the Impact of Melatonin and Captopril on Early Effects of Radiation on the Heart Tissue by Studying GSH, MDA and LDH Enzyme Activity in Rats (#413)

Farnaz Tabatabaie